Stockreport

Annexon Announces Pricing of $75 Million Public Offering of Common Stock and Pre-Funded Warrants [Yahoo! Finance]

Annexon, Inc. - common stock  (ANNX) 
PDF biopharmaceutical company advancing a late-stage clinical platform targeting neuroinflammation across life-changing complement-mediated diseases of the body, brain, and [Read more]